PACS developer IDX Systems will provide Penn State Milton S. Hershey Medical Center and Penn State College of Medicine with a Web-based product designed to support enterprise access to diagnostic quality images, seamless
PACS developer IDX Systems will provide Penn State Milton S. Hershey Medical Center and Penn State College of Medicine with a Web-based product designed to support enterprise access to diagnostic quality images, seamless integration of associated patient and exam information, and secure online storage. The agreement includes vnetix, which will streamline the process of medical imaging from patient scanning to diagnostic interpretation and reporting, online archive storage, and enterprise distribution to referring providers. The agreement also includes IDXrad, the company's Web-based radiology information system. Together, vnetix and IDXrad will provide end-to-end management of all images and information for the enterprise, which conducts more than 200,000 radiology exams each year.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.